These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2437089)

  • 1. HLA-A2 epitopes recognized by alloantibodies from broadly sensitized patients.
    Scornik JC
    Hum Immunol; 1987 Apr; 18(4):277-85. PubMed ID: 2437089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topographic map of the HLA-A2 CREG epitopes using human alloantibody probes.
    Fuller AA; Trevithick JE; Rodey GE; Parham P; Fuller TC
    Hum Immunol; 1990 Jul; 28(3):284-305. PubMed ID: 1695623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the repertoire of anti-HLA antibodies with anti-idiotypes to a murine anti-HLA-A2,A28 monoclonal antibody.
    Russo C; Pellegrino MA; Ferrone S
    Hum Immunol; 1984 May; 10(1):57-67. PubMed ID: 6609912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid residues 56 to 69 of HLA-A2 specify an antigenic determinant shared by HLA-A2 and HLA-B17.
    Ways JP; Rothbard JB; Parham P
    J Immunol; 1986 Jul; 137(1):217-22. PubMed ID: 2423602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The binding of monoclonal antibodies to cell-surface molecules. A quantitative analysis with immunoglobulin G against two alloantigenic determinants of the human transplantation antigen HLA-A2.
    Ways JP; Parham P
    Biochem J; 1983 Nov; 216(2):423-32. PubMed ID: 6197968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intramolecular specificity of anti-HLA alloantibodies.
    Akkoc N; Scornik JC
    Hum Immunol; 1991 Feb; 30(2):91-8. PubMed ID: 2022498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A monoclonal antibody recognizing a determinant shared by HLA-A2 and HLA-Aw69 (A28* variant).
    Antonelli P; Choo SY; Nisperos B; Hansen JA
    Tissue Antigens; 1985 Aug; 26(2):114-20. PubMed ID: 2414860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal T lymphocyte recognition of the fine structure of the HLA-A2 molecule.
    Brenner MB; McLean J; Yang SY; van der Poel JJ; Pious D; Strominger JL
    J Immunol; 1985 Jul; 135(1):384-90. PubMed ID: 2582041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mAb against HLA-A2 can be influenced both positively and negatively by the associated peptide.
    Barouch D; Davenport M; McMichael A; Reay P
    Int Immunol; 1995 Oct; 7(10):1599-605. PubMed ID: 8562505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct binding to antigen-coated beads refines the specificity and cross-reactivity of four monoclonal antibodies that recognize polymorphic epitopes of HLA class I molecules.
    Hilton HG; Parham P
    Tissue Antigens; 2013 Apr; 81(4):212-20. PubMed ID: 23510417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA class I epitopes: recognition of binding sites by mAbs or eluted alloantibody confirmed with single recombinant antigens.
    El-Awar N; Lee JH; Tarsitani C; Terasaki PI
    Hum Immunol; 2007 Mar; 68(3):170-80. PubMed ID: 17349872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allo-antibodies to an antigenic determinant shared by HLA-A2 and B17.
    Claas F; Castelli-Visser R; Schreuder I; van Rood J
    Tissue Antigens; 1982 May; 19(5):388-91. PubMed ID: 6180520
    [No Abstract]   [Full Text] [Related]  

  • 13. A cytotoxic monoclonal IgM antibody (Tü 101) directed against an antigenic determinant shared between the HLA-A allospecificities A2 and A28.
    Müller C; Liangru S; Schneider M; Ziegler A; Wernet P
    Hum Immunol; 1983 Apr; 6(4):189-97. PubMed ID: 6188732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antigenic structure of HLA-A2: an analysis with competitive binding assays and monoclonal antibodies.
    Ways JP; Parham P
    J Immunol; 1983 Aug; 131(2):856-63. PubMed ID: 6190942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antibody response to an HLA mismatch: a model for nonself-self discrimination in relation to HLA epitope immunogenicity.
    Duquesnoy RJ
    Int J Immunogenet; 2012 Feb; 39(1):1-9. PubMed ID: 21981757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to crossreactive HLA antigens. Evaluation by cytotoxicity, flow cytometry, and inhibition of monoclonal antibody binding.
    Scornik JC; LeFor WM
    Transplantation; 1987 Feb; 43(2):235-40. PubMed ID: 3544381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivity patterns with HLA-A2 variants indicate lack of identity between determinants defined by monoclonal antibodies and cytotoxic-T-cell clones.
    Russo C; Flomenberg N; Dupont B; Ferrone S
    Cell Immunol; 1984 Oct; 88(1):228-32. PubMed ID: 6206957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human leukocyte antigen class I epitopes: update to 103 total epitopes, including the C locus.
    El-Awar NR; Akaza T; Terasaki PI; Nguyen A
    Transplantation; 2007 Aug; 84(4):532-40. PubMed ID: 17713439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenesis around residue 176 on HLA-B*0702 characterizes multiple distinct epitopes for anti-HLA antibodies.
    McCutcheon JA; Lutz CT
    Hum Immunol; 1992 Oct; 35(2):125-31. PubMed ID: 1283748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the alpha-1 helix.
    Lutz CT; Smith KD; Greazel NS; Mace BE; Jensen DA; McCutcheon JA; Goeken NE
    J Immunol; 1994 Nov; 153(9):4099-110. PubMed ID: 7523516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.